1921
Volume 82, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Historically, poliovirus infection has been an important cause of acute flaccid paralysis (AFP) worldwide; however, successful elimination of wild-type poliovirus in much of the world has highlighted the importance of other causes of AFP. Despite the evolving etiology, AFP surveillance in most developing countries still focuses on poliovirus detection and fails to detect many AFP cases, particularly among adults. We assessed 41 subjects self-reporting symptoms suggestive of AFP during a population-based health survey in the Department of Santa Rosa, Guatemala. Thirty-five (85%) of the suspected cases were not hospitalized. Most subjects (37) did not have features consistent with AFP or had other diagnoses explaining weakness. We identified two adults who had not received medical attention for a clinical illness consistent with Guillain-Barré syndrome, the most important cause of non-poliovirus AFP. Usual surveillance methods for AFP, particularly in developing countries, may underestimate the true burden of non-poliovirus AFP.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2010.09-0090
2010-04-05
2019-10-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/82/4/712.html?itemId=/content/journals/10.4269/ajtmh.2010.09-0090&mimeType=html&fmt=ahah

References

  1. Solomon T, Willison H, , 2003. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis 16: 375381.[Crossref] [Google Scholar]
  2. Ward NA, Milstien JB, Hull HF, Hull BP, Kim-Farley RJ, , 1993. The WHO-EPI initiative for the global eradication of poliomyelitis. Biologicals 21: 327333.[Crossref] [Google Scholar]
  3. Cornblath DR, Hughes RC, Kimura J, , 2006. Guillain-Barre syndrome. , ed. Handbook of Clinical Neurophysiology. Philadelphia: Elsevier, 695708. [Google Scholar]
  4. Hughes RA, Cornblath DR, , 2005. Guillain-Barre syndrome. Lancet 366: 16531666.[Crossref] [Google Scholar]
  5. Bahemuka M, , 1988. Guillain-Barre syndrome in Kenya: a clinical review of 54 patients. J Neurol 235: 418421.[Crossref] [Google Scholar]
  6. Barzegar M, Dastgiri S, Karegarmaher MH, Varshochiani A, , 2007. Epidemiology of childhood Guillan-Barre syndrome in the north west of Iran. BMC Neurol 7: 22.[Crossref] [Google Scholar]
  7. Hart DE, Rojas LA, Rosario JA, Recalde H, Roman GC, , 1994. Childhood Guillain-Barre syndrome in Paraguay, 1990 to 1991. Ann Neurol 36: 859863.[Crossref] [Google Scholar]
  8. Hussain IH, Ali S, Sinniah M, Kurup D, Khoo TB, Thomas TG, Apandi M, Taha AM, 2004. Five-year surveillance of acute flaccid paralysis in Malaysia. J Paediatr Child Health 40: 127130.[Crossref] [Google Scholar]
  9. London L, Bourne D, Sayed R, Eastman R, , 2004. Guillain-Barre syndrome in a rural farming district in South Africa: a possible relationship to environmental organophosphate exposure. Arch Environ Health 59: 575580.[Crossref] [Google Scholar]
  10. Rocha MS, Brucki SM, Carvalho AA, Lima UW, , 2004. Epidemiologic features of Guillain-Barre syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatr 62: 3337.[Crossref] [Google Scholar]
  11. Shafqat S, Khealani BA, Awan F, Abedin SE, , 2006. Guillain-Barre syndrome in Pakistan: similarity of demyelinating and axonal variants. Eur J Neurol 13: 662665.[Crossref] [Google Scholar]
  12. Visudtibhan A, Visudhiphan P, Chiemchanya S, Wiengperm M, , 1998. Guillain-Barre syndrome in Thai children: retrospective analysis of the clinical and outcome prior to intravenous immune globulin era. J Med Assoc Thai 81: 750756. [Google Scholar]
  13. Arvelo W, , ed, 2006. Community household survey to describe healthcare utilization practices and risk factors for diarrheal diseases in the Department of Santa Rosa, Guatemala–2006 (Abstract #988). Proceedings of the 45th Annual Meeting of the Infectious Diseases Society of America; San Diego, CA, October 2007. [Google Scholar]
  14. Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, Noda M, , 1998. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome. Ann Neurol 44: 202208.[Crossref] [Google Scholar]
  15. Green DM, Ropper AH, , 2001. Mild Guillain-Barre syndrome. Arch Neurol 58: 10981101.[Crossref] [Google Scholar]
  16. Berger AR, Logigian EL, Shahani BT, , 1988. Reversible proximal conduction block underlies rapid recovery in Guillain-Barre syndrome. Muscle Nerve 11: 10391042.[Crossref] [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.09-0090
Loading
/content/journals/10.4269/ajtmh.2010.09-0090
Loading

Data & Media loading...

  • Received : 16 Feb 2009
  • Accepted : 26 Dec 2009
  • Published online : 05 Apr 2010

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error